Background: The newly developed multi-frequency transcranial Doppler (TCD) is able to differentiate gaseous from solid emboli. Our goal was to apply this technology to initially characterize emboli detected during carotid stenting with distal protection. Methods: Patients undergoing carotid angiography and stenting were monitored with 2–2.5 MHz TCD (Embo-Dop, DWL) over the middle cerebral artery unilateral to stent deployment. Sonographers insured optimal signal recordings during the procedures. Automated emboli detection and classification software (MultiXLab version 2.0) was applied for offline count and analysis. Monitoring using the Filter Wire EX (Boston Scientific) and ACCUNET system (Guidant Corporation) was performed. Results: A total of 9,649 embolic signals were detected during 11 angiographic and 10 stenting procedures. An observer confirmed the signals using the International Consensus definition. Automated software classified these events into 5,900 gaseous and 3,749 solid emboli. During contrast injections without the protection device, 1,013 emboli were detected with 28% of these being solid. With deployment of the distal protection device, 8,636 emboli were found with 40% being solid (p < 0.001). During stenting and angioplasty with the protection device, 7,395 emboli with 42% solids were detected (p < 0.001). Finally injection of contrast after the procedure, with the protection device still deployed, yielded 1,241 emboli with 31% solids (NS). Only 1 patient developed transient hemiparesthesia during ballooning that reduced the flow velocity to zero for 14 s. Neither gaseous nor solid emboli resulted in a mean flow velocity decrease or clinical symptoms. Conclusions: Microembolization frequently occurs during stenting even with deployment of the distal protection device. More solid emboli are seen during manipulations associated with lesion crossing. Although novel TCD methods yield a high frequency of embolic signals, further validation of this technique to determine the true nature, size, and number of emboli is needed.

Keywords:
Carotid arteries, Embolism, Stenosis, Transcranial Doppler
1.
Wholey MH, Wholey M, Mathias K, Roubin GS, Diethrich EB, Henry M, et al: Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv 2000;50:160–167.
2.
Roubin GS, New G, Iyer SS, Vitek JJ, Al-Mubarak N, Liu MW, et al: Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis. Circulation 2001;103:532–537.
3.
Fayad P: Results of SAPPHIRE trial. 28th ASA Stroke Conference, Phoenix, 2003.
4.
Crawley F, Clifton A, Buckenham T, Loosemore T, Taylor RS, Brown MM: Comparison of hemodynamic cerebral ischemia and microembolic signals detected during carotid endarterectomy and carotid angioplasty. Stroke 1997;28:2460–2464.
5.
Reimers B, Corvaja N, Moshiri S, Sacca S, Albiero R, Di Mario C, et al: Cerebral protection with filter devices during carotid artery stenting. Circulation 2001;104:12–15.
6.
Cremonesi A, Manetti R, Setacci F, Setacci C, Castriota F: Protected carotid stenting: clinical advantages and complications of embolic protection devices in 442 consecutive patients. Stroke 2003;34:1936–1941.
7.
Parodi JC, La Mura R, Ferreira LM, Mendez MV, Cersosimo H, Schonholz C, et al: Initial evaluation of carotid angioplasty and stenting with three different cerebral protection devices. J Vasc Surg 2000;32:1127–1136.
8.
Al-Mubarak N, Colombo A, Gaines PA, Iyer SS, Corvaja N, Cleveland TJ, et al: Multicenter evaluation of carotid artery stenting with a filter protection system. J Am Coll Cardiol 2002;39:841–846.
9.
Albuquerque FC, Teitelbaum GP, Lavine SD, Larsen DW, Giannotta SL: Balloon-protected carotid angioplasty. Neurosurgery 2000;46:918–923.
10.
Spencer MP: Transcranial Doppler monitoring and causes of stroke from carotid endarterectomy. Stroke 1997;28:685–691.
11.
Markus H: Monitoring embolism in real time. Circulation 2000;102:826–828.
12.
Brucher R, Russell D: Automatic online embolus detection and artifact rejection with the first multifrequency transcranial Doppler. Stroke 2002;33:1969–1974.
13.
Russell D, Brucher R: Online automatic discrimination between solid and gaseous cerebral microemboli with the first multifrequency transcranial Doppler. Stroke 2002;33:1975–1980.
14.
Hobson RW 2nd: Update on the Carotid Revascularization Endarterectomy versus Stent Trial (CREST) protocol. J Am Coll Surg. 2002;194(suppl 1):S9–S14.
15.
Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis: North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991;325:445–453.
16.
Ringelstein EB, Droste DW, Babikian VL, Evans DH, Grosset DG, Kaps M, et al: Consensus on microembolus detection by TCD. International Consensus Group on Microembolus Detection. Stroke 1998;29:725–729.
17.
Markus H, Loh A, Israel D, Buckenham T, Clifton A, Brown MM: Microscopic air embolism during cerebral angiography and strategies for its avoidance. Lancet 1993;341:784–787.
18.
Orlandi G, Fanucchi S, Fioretti C, Acerbi G, Puglioli M, Padolecchia R, et al: Characteristics of cerebral microembolism during carotid stenting and angioplasty alone. Arch Neurol 2001;58:1410–1413.
19.
Brucher R, Russell D: Background and principles; in Tegeler CH, Babikian VL, Gomes CR (eds): Neurosonology. St Louis, Mosby-Year Book, 1996, pp 231–234.
20.
Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet 2001;357:1729–1737.
21.
Golledge J, Mitchell A, Greenhalgh RM, Davies AH: Systematic comparison of the early outcome of angioplasty and endarterectomy for symptomatic carotid artery disease. Stroke 2000;31:1439–1443.
22.
Jordan WD Jr, Voellinger DC, Doblar DD, Plyushcheva NP, Fisher WS, McDowell HA: Microemboli detected by transcranial Doppler monitoring in patients during carotid angioplasty versus carotid endarterectomy. Cardiovasc Surg 1999;7:33–38.
23.
Barth A, Remonda L, Lovblad KO, Schroth G, Seiler RW: Silent cerebral ischemia detected by diffusion-weighted MRI after carotid endarterectomy. Stroke 2000;31:1824–1828.
24.
Jaeger HJ, Mathias KD, Hauth E, Drescher R, Gissler HM, Hennigs S, et al: Cerebral ischemia detected with diffusion-weighted MR imaging after stent implantation in the carotid artery. AJNR Am J Neuroradiol 2002;23:200–207.
25.
Castriota F, Cremonesi A, Manetti R, Liso A, Oshola K, Ricci E, et al: Impact of cerebral protection devices on early outcome of carotid stenting. J Endovasc Ther 2002;9:786–792.
26.
Al-Mubarak N, Roubin GS, Vitek JJ, Iyer SS, New G, Leon MB: Effect of the distal-balloon protection system on microembolization during carotid stenting. Circulation 2001;104:1999–2002.
27.
Kidwell CS, Alger JR, Di Salle F, Starkman S, Villablanca P, Bentson J, et al: Diffusion MRI in patients with transient ischemic attacks. Stroke 1999;30:1174–1180.
28.
Stump DA, Kon NA, Rogers AT, Hammon JW: Emboli and neuropsychological outcome following cardiopulmonary bypass. Echocardiography 1996;13:555–558.
29.
Pugsley W, Klinger L, Paschalis C, Treasure T, Harrison M, Newman S: The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning. Stroke 1994;25:1393–1399.
30.
Russell D: Cerebral microemboli and cognitive impairment. J Neurol Sci 2002;203–204:211–214.
31.
Jaeger HJ, Mathias KD, Drescher R, Hauth E, Bockisch G, Demirel E, et al: Diffusion-weighted MR imaging after angioplasty or angioplasty plus stenting of arteries supplying the brain. AJNR Am J Neuroradiol 2001;22:1251–1259.
32.
Schluter M, Tubler T, Steffens JC, Mathey DG, Schofer J: Focal ischemia of the brain after neuroprotected carotid artery stenting. J Am Coll Cardiol 2003;42:1007–1013.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.